Department of Animal and Avian Sciences, University of Maryland, College Park, MD 20742, USA.
Biochem Biophys Res Commun. 2012 Aug 3;424(3):635-40. doi: 10.1016/j.bbrc.2012.07.018. Epub 2012 Jul 15.
Cytotoxic T lymphocytes (CTLs) play a critical role in controlling intracellular pathogens and cancer cells, and induction of memory CTLs holds promise for developing effective vaccines against critical virus infections. However, generating memory CTLs remains a major challenge for conventional vector-based, prime-boost vaccinations. Thus, it is imperative that we explore nonconventional alternatives, such as boosting without vectors. We show here that repetitive intravenous boosting with peptide and adjuvant generates memory CD8 T cells of sufficient quality and quantity to protect against infection in mice. The resulting memory CTLs possess a unique and long-lasting effector memory phenotype, characterized by decreased interferon-γ but increased granzyme B production. These results are observed in both transgenic and endogenous models. Overall, our findings have important implications for future vaccine development, as they suggest that intravenous peptide boosting with adjuvant following priming can induce long-term functional memory CTLs.
细胞毒性 T 淋巴细胞 (CTLs) 在控制细胞内病原体和癌细胞方面发挥着关键作用,诱导记忆 CTLs 有望为对抗关键病毒感染开发有效的疫苗。然而,对于传统的基于载体的初免-加强免疫接种来说,产生记忆 CTLs 仍然是一个主要挑战。因此,我们必须探索非传统的替代方法,例如无载体的加强免疫。我们在这里表明,用肽和佐剂进行重复静脉内加强免疫可产生足够数量和质量的记忆 CD8 T 细胞,以保护小鼠免受感染。由此产生的记忆 CTLs 具有独特且持久的效应记忆表型,其特征是干扰素-γ 减少,但颗粒酶 B 的产生增加。这些结果在转基因和内源性模型中都有观察到。总的来说,我们的研究结果对未来的疫苗开发具有重要意义,因为它们表明,在初免后用佐剂进行静脉内肽加强免疫可以诱导长期功能性记忆 CTLs。